Cholesteatoma has an altered microbiota with a higher abundance of Staphylococcus species

Abstract Objective To compare the microbiota between cholesteatoma and chronic suppurative otitis media (COM) and to identify potential pathogens that explain the relevant phenotypes of cholesteatoma. Study Design Prospective cohort study. Methods Surgical specimens collected from 20 cholesteatomas and nine COMs were treated to dissolve biofilms and subjected to 16S ribosomal RNA (rRNA) gene sequencing and amplicon sequence variant‐level analysis for microbiota profiling and quantitative comparison. Correlations between the relative abundance of potential pathogens and the volume of the primary resected cholesteatomas were examined. Results Differences in bacterial composition (beta diversity) were observed between cholesteatomas and COM ( p = .002), with a higher abundance of Staphylococcus in cholesteatomas than in COM ( p = .005). Common genera in the external auditory canal (EAC) flora, such as Staphylococcus, Corynebacterium, and Cutibacterium, were predominant in both cholesteatoma and COM; Staphylococcus aureus and Pseudomonas aeruginosa were increased in both diseases compared with the EAC flora. Furthermore, coagulase‐negative staphylococci (CoNS) were more abundant in cholesteatomas than in COM ( p = 0.002). Linear discriminant analysis coupled with effect size measurements (LEfSe) identified four CoNS as potential biomarkers for cholesteatoma. The relative abundance of S. aureus, a potential pathogen, was positively correlated with cholesteatoma volume ( r = .60, p = .02). Conclusion The microbiota of cholesteatoma and COM originated from EAC flora, but the bacterial composition was largely altered. Our results suggested that S. aureus infection is involved in cholesteatoma progression. Level of Evidence3b.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:7

Enthalten in:

Laryngoscope Investigative Otolaryngology - 7(2022), 6, Seite 2011-2019

Beteiligte Personen:

Fujikawa, Taro [VerfasserIn]
Tanimoto, Kousuke [VerfasserIn]
Kawashima, Yoshiyuki [VerfasserIn]
Ito, Taku [VerfasserIn]
Honda, Keiji [VerfasserIn]
Takeda, Takamori [VerfasserIn]
Sonobe, Akane [VerfasserIn]
Aoki, Natsuki [VerfasserIn]
Bai, Jing [VerfasserIn]
Tsutsumi, Takeshi [VerfasserIn]

Anmerkungen:

© 2022 The American Laryngological, Rhinological and Otological Society, Inc.

Umfang:

9

doi:

10.1002/lio2.934

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WLY00971667X